These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 34352171)

  • 1. EP2 Antagonists (2011-2021): A Decade's Journey from Discovery to Therapeutics.
    Sluter MN; Hou R; Li L; Yasmen N; Yu Y; Liu J; Jiang J
    J Med Chem; 2021 Aug; 64(16):11816-11836. PubMed ID: 34352171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostanoid receptor EP2 as a therapeutic target.
    Ganesh T
    J Med Chem; 2014 Jun; 57(11):4454-65. PubMed ID: 24279689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.
    Bonfill-Teixidor E; Otxoa-de-Amezaga A; Font-Nieves M; Sans-Fons MG; Planas AM
    J Neuroinflammation; 2017 Jan; 14(1):3. PubMed ID: 28086956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection.
    Jiang J; Dingledine R
    Trends Pharmacol Sci; 2013 Jul; 34(7):413-23. PubMed ID: 23796953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripherally Restricted, Highly Potent, Selective, Aqueous-Soluble EP2 Antagonist with Anti-Inflammatory Properties.
    Ganesh T; Banik A; Dingledine R; Wang W; Amaradhi R
    Mol Pharm; 2018 Dec; 15(12):5809-5817. PubMed ID: 30398879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule antagonist reveals seizure-induced mediation of neuronal injury by prostaglandin E2 receptor subtype EP2.
    Jiang J; Ganesh T; Du Y; Quan Y; Serrano G; Qui M; Speigel I; Rojas A; Lelutiu N; Dingledine R
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):3149-54. PubMed ID: 22323596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor.
    Säfholm J; Manson ML; Bood J; Delin I; Orre AC; Bergman P; Al-Ameri M; Dahlén SE; Adner M
    J Allergy Clin Immunol; 2015 Nov; 136(5):1232-9.e1. PubMed ID: 25962903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EP
    Bradbury P; Rumzhum NN; Ammit AJ
    J Cell Physiol; 2019 Jul; 234(7):11070-11077. PubMed ID: 30536718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting EP2 Receptor for Drug Discovery: Strengths, Weaknesses, Opportunities, and Threats (SWOT) Analysis.
    Ganesh T
    J Med Chem; 2023 Jul; 66(14):9313-9324. PubMed ID: 37458373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the EP receptor subtype that mediates the inhibitory effects of prostaglandin E2 on IgE-dependent secretion from human lung mast cells.
    Kay LJ; Gilbert M; Pullen N; Skerratt S; Farrington J; Seward EP; Peachell PT
    Clin Exp Allergy; 2013 Jul; 43(7):741-51. PubMed ID: 23786281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2-dependent prostaglandin E2 down-regulates intercellular adhesion molecule-1 expression via EP2/EP4 receptors in interleukin-1beta-stimulated human gingival fibroblasts.
    Noguchi K; Iwasaki K; Shitashige M; Endo H; Kondo H; Ishikawa I
    J Dent Res; 2000 Dec; 79(12):1955-61. PubMed ID: 11201045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic window for cyclooxygenase-2 related anti-inflammatory therapy after status epilepticus.
    Jiang J; Yang MS; Quan Y; Gueorguieva P; Ganesh T; Dingledine R
    Neurobiol Dis; 2015 Apr; 76():126-136. PubMed ID: 25600211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EP2/4 Receptors Promote the Synthesis of PGE
    Zhang C; Wang L; Li T; Mao W; Liu B; Cao J
    J Pharmacol Exp Ther; 2020 Feb; 372(2):175-184. PubMed ID: 31732699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AH6809 decreases production of inflammatory mediators by PGE
    Li P; Jiang H; Wu H; Wu D; Li H; Yu J; Lai J
    Brain Res; 2018 Nov; 1698():11-28. PubMed ID: 29792868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype.
    Kang X; Qiu J; Li Q; Bell KA; Du Y; Jung DW; Lee JY; Hao J; Jiang J
    Sci Rep; 2017 Aug; 7(1):9459. PubMed ID: 28842681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E2-EP2-NF-κB signaling in macrophages as a potential therapeutic target for intracranial aneurysms.
    Aoki T; Frȍsen J; Fukuda M; Bando K; Shioi G; Tsuji K; Ollikainen E; Nozaki K; Laakkonen J; Narumiya S
    Sci Signal; 2017 Feb; 10(465):. PubMed ID: 28174280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EP2 and EP4 receptors mediate PGE2 induced relaxation in murine colonic circular muscle: pharmacological characterization.
    Martinez-Cutillas M; Mañé N; Gallego D; Jimenez M; Martin MT
    Pharmacol Res; 2014 Dec; 90():76-86. PubMed ID: 25461458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of the prostaglandin E2 EP2 receptor reduces oxidative damage and amyloid burden in a model of Alzheimer's disease.
    Liang X; Wang Q; Hand T; Wu L; Breyer RM; Montine TJ; Andreasson K
    J Neurosci; 2005 Nov; 25(44):10180-7. PubMed ID: 16267225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors.
    Francica BJ; Holtz A; Lopez J; Freund D; Chen A; Wang D; Powell D; Kipper F; Panigrahy D; Dubois RN; Whiting CC; Prasit P; Dubensky TW
    Cancer Res Commun; 2023 Aug; 3(8):1486-1500. PubMed ID: 37559947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostanoids and inflammatory pain.
    Chen L; Yang G; Grosser T
    Prostaglandins Other Lipid Mediat; 2013; 104-105():58-66. PubMed ID: 22981510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.